Will We Ever Know the Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation?

被引：12

作者：

Kastrati, Adnan ^{[1
]}

Byrne, Robert A. ^{[1
]}

Schulz, Stefanie ^{[1
]}

机构：

[1] Tech Univ Munich, Deutsch Herzzentrum, D-80636 Munich, Germany

来源：

JACC-CARDIOVASCULAR INTERVENTIONS | 2011年 / 4卷 / 10期

关键词：

antiplatelet therapy; dopidogrel; drugeluting stent(s); PERCUTANEOUS CORONARY INTERVENTION; BIODEGRADABLE POLYMER; ARTERY-DISEASE; CLOPIDOGREL; THROMBOSIS; REVASCULARIZATION; OUTCOMES; ASPIRIN; TRIALS; DISCONTINUATION;

D O I：

10.1016/j.jcin.2011.08.003

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1129 / 1132

页数：4

共 27 条

[1] Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment [J].

Airoldi, Flavio ;

Colombo, Antonio ;

Morici, Nuccia ;

Latib, Azeem ;

Cosgrave, John ;

Buellesfeld, Lutz ;

Bonizzoni, Erminio ;

Carlino, Mauro ;

Gerckens, Ulrich ;

Godino, Cosmo ;

Melzi, Gloria ;

Michev, Iassen ;

Montorfano, Matteo ;

Sangiorgi, Giuseppe Massimo ;

Qasim, Asif ;

Chieffo, Alaide ;

Briguori, Carlo ;

Grube, Eberhard .

CIRCULATION, 2007, 116 (07) :745-754

[2] Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events [J].

Bhatt, DL ;

Fox, KAA ;

Hacke, W ;

Berger, PB ;

Black, HR ;

Boden, WE ;

Cacoub, P ;

Cohen, EA ;

Creager, MA ;

Easton, JD ;

Flather, MD ;

Haffner, SM ;

Hamm, CW ;

Hankey, GJ ;

Johnston, SC ;

Mak, KH ;

Mas, JL ;

Montalescot, G ;

Pearson, TA ;

Steg, PG ;

Steinhubl, SR ;

Weber, MA ;

Brennan, DM ;

Fabry-Ribaudo, L ;

Booth, J ;

Topol, EJ ;

Frye, RL ;

Amarenco, P ;

Brass, LM ;

Buyse, M ;

Cohen, LS ;

DeMets, DL ;

Fuster, V ;

Hart, RG ;

Marler, JR ;

McCarthy, C ;

Schoemig, A ;

Lincoff, AM ;

Brener, SJ ;

Sila, CA ;

Albuquerque, A ;

Aroutiounov, G ;

Artemiev, D ;

Atkeson, BG ;

Bartel, T ;

Basart, DCG ;

Lima, AB ;

Belli, G ;

Bordalo e Sa, AL ;

Bosch, X .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (16) :1706-1717

[3] Biodegradable Polymer Versus Permanent Polymer Drug-Eluting Stents and Everolimus- Versus Sirolimus-Eluting Stents in Patients With Coronary Artery Disease 3-Year Outcomes From a Randomized Clinical Trial [J].

Byrne, Robert A. ;

Kastrati, Adnan ;

Massberg, Steffen ;

Wieczorek, Anna ;

Laugwitz, Karl-Ludwig ;

Hadamitzky, Martin ;

Schulz, Stefanie ;

Pache, Juergen ;

Fusaro, Massimiliano ;

Hausleiter, Joerg ;

Schoemig, Albert ;

Mehilli, Julinda .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (13) :1325-1331

[4] Prevention of premature ditscontinuation of dual antiplatelet therapy in patients with coronary artery stents [J].

Grines, Cindy L. ;

Bonow, Robert O. ;

Casey, Donald E., Jr. ;

Gardner, Timothy J. ;

Lockhart, Peter B. ;

Moliterno, David J. ;

O'Gara, Patrick ;

Whitlow, Patrick .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (06) :734-739

[5]

GWON HC, 2011, AM COLL CARD 2011 SC

[6] Pathology of drug-eluting stents in humans - Delayed healing and late thrombotic risk [J].

Joner, Michael ;

Finn, Aloke V. ;

Farb, Andrew ;

Mont, Erik K. ;

Kolodgie, Frank D. ;

Ladich, Elena ;

Kutys, Robert ;

Skorija, Kristi ;

Gold, Herman K. ;

Virmani, Renu .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (01) :193-202

[7] Dual Antiplatelet Therapy Duration and Clinical Outcomes Following Treatment With Zotarolimus-Eluting Stents [J].

Kandzari, David E. ;

Barker, Colin S. ;

Leon, Martin B. ;

Mauri, Laura ;

Wijns, William ;

Fajadet, Jean ;

Mehran, Roxana .

JACC-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (10) :1119-1128

[8] Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents [J].

Kastrati, Adnan ;

Mehilli, Julinda ;

Pache, Juergen ;

Kaiser, Christoph ;

Valgimigli, Marco ;

Kelbaek, Henning ;

Menichelli, Maurizio ;

Sabate, Manel ;

Suttorp, Maarten J. ;

Baumgart, Dietrich ;

Seyfarth, Melchior ;

Pfisterer, Matthias E. ;

Schoemig, Albert .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (10) :1030-1039

[9] Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation [J].

Kimura, Takeshi ;

Morimoto, Takeshi ;

Nakagawa, Yoshihisa ;

Tamura, Toshihiro ;

Kadota, Kazushige ;

Yasumoto, Hitoshi ;

Nishikawa, Hideo ;

Hiasa, Yoshikazu ;

Muramatsu, Toshiya ;

Meguro, Taiichiro ;

Inoue, Naoto ;

Honda, Hidehiko ;

Hayashi, Yasuhiko ;

Miyazaki, Shunichi ;

Oshima, Shigeru ;

Honda, Takashi ;

Shiode, Nobuo ;

Namura, Masanobu ;

Sone, Takahito ;

Nobuyoshi, Masakiyo ;

Kita, Toru ;

Mitsudo, Kazuaki .

CIRCULATION, 2009, 119 (07) :987-U120

[10] Polymer-Free Sirolimus- and Probucol-Eluting Versus New Generation Zotarolimus-Eluting Stents in Coronary Artery Disease The Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting Versus Zotarolimus-Eluting Stents (ISAR-TEST 5) Trial [J].

Massberg, Steffen ;

Byrne, Robert A. ;

Kastrati, Adnan ;

Schulz, Stefanie ;

Pache, Juergen ;

Hausleiter, Joerg ;

Ibrahim, Tareq ;

Fusaro, Massimiliano ;

Ott, Ilka ;

Schoemig, Albert ;

Laugwitz, Karl-Ludwig ;

Mehilli, Julinda .

CIRCULATION, 2011, 124 (05) :624-632

← 1 2 3 →